Evidence Hub

Oxyberberine alleviates fructose-induced hyperuricemia by modulating purine metabolism and gut microbiota

Tan W, Xie X, Yu Q, Yan G, Chen H, Xie Q, Liu Y, Huang X et al.

European journal of pharmacology, 2025

Abstract

Phellodendri Chinensis Cortex, a time-honored Chinese materia medica, has long been applied in the management of gout and other diseases. Hyperuricemia (HUA) is the vital contributor for the occurrence and progression of gout. Oxyberberine (OBB), an oxidized protoberberine alkaloid, is naturally present in Phellodendri Chinensis Cortex. The work made a pioneering endeavor to unravel the potential anti-HUA effect and mechanism of OBB. Hight fructose-induced experimental HUA in rats was employed. Results indicated that OBB significantly reduced the body weight and UA level, and concurrently mitigated hepatic injury, which achieved superior therapeutic effect to its prodrug berberine (BBR). OBB treatment remarkably alleviated inflammatory response and oxidative stress. Furthermore, OBB appreciably activated the gene expression of key enzymes involved in the pentose phosphate pathway (PPP), and inhibited the transcriptional or translational expression of key enzymes in de novo purine biosynthesis (DNPB), as well as modulated purine salvage pathway (PSP), collectively leading to a reduction in UA level. Molecular docking and dynamic simulation further confirmed the dynamic stability of OBB-target protein complexes. Meanwhile, OBB favorably modulated the fructose-induced gut dysbiosis, enhanced the abundance of probiotics and abated detrimental counterparts, which were associated with promoting UA catabolism and inhibiting inflammation response via correlation analysis. In…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free